MRD as a Guide: Redefining MyelomaTreatment with Precision Immunotherapy

Discover how measurable residual disease (MRD) is transforming the treatment landscape in multiple myeloma. In this video, we explore how MRD testing is being used as a powerful guide to personalize therapy, measure treatment response, and shape the future of precision immunotherapy. Learn how advanced MRD detection techniques help doctors identify even tiny amounts of remaining myeloma cells, enabling more informed decisions about treatment intensity, duration, and next steps.